These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 24548873)

  • 1. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma.
    Kim IK; Lane AM; Egan KM; Munzenrider J; Gragoudas ES
    Ophthalmology; 2010 Aug; 117(8):1617-22. PubMed ID: 20363507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
    Finger PT; Chin KJ; Tena LB
    Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
    Sagoo MS; Shields CL; Emrich J; Mashayekhi A; Komarnicky L; Shields JA
    JAMA Ophthalmol; 2014 Jun; 132(6):697-702. PubMed ID: 24652552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
    Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007.
    Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):121-8. PubMed ID: 21945109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
    Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of low-dose proton beam therapy for circumscribed choroidal hemangiomas.
    Levy-Gabriel C; Rouic LL; Plancher C; Dendale R; Delacroix S; Asselain B; Habrand JL; Desjardins L
    Retina; 2009 Feb; 29(2):170-5. PubMed ID: 18997642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal dexamethasone 0.7-mg implant for radiation macular edema after proton beam therapy for choroidal melanoma.
    Baillif S; Maschi C; Gastaud P; Caujolle JP
    Retina; 2013 Oct; 33(9):1784-90. PubMed ID: 23652581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-Induced Optic Neuropathy: Observation versus Intravitreal Treatment: Can Visual Acuity Be Maintained by Intravitreal Treatment?
    Eckstein D; Riechardt AI; Heufelder J; Zeitz O; Böker A; Brockmann C; Joussen AM; Seibel I
    Am J Ophthalmol; 2019 Dec; 208():289-294. PubMed ID: 31323201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone.
    Schönfeld S; Cordini D; Riechardt AI; Seibel I; Willerding G; Bechrakis NE; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Dec; 158(6):1184-91. PubMed ID: 25128597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency.
    Tran E; Ma R; Paton K; Blackmore E; Pickles T
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1425-31. PubMed ID: 22209152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
    Semenova E; Finger PT
    JAMA Ophthalmol; 2014 Feb; 132(2):205-13. PubMed ID: 24287555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients.
    Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
    Arch Ophthalmol; 2008 Nov; 126(11):1515-22. PubMed ID: 19001218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome.
    De Potter P; Shields CL; Shields JA; Cater JR; Brady LW
    Arch Ophthalmol; 1996 Nov; 114(11):1357-65. PubMed ID: 8906026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide for acute radiation papillopathy.
    Shields CL; Demirci H; Marr BP; Mashayekhi A; Dai VV; Materin MA; Shields JA
    Retina; 2006; 26(5):537-44. PubMed ID: 16770260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton irradiation for peripapillary and parapapillary melanomas.
    Lane AM; Kim IK; Gragoudas ES
    Arch Ophthalmol; 2011 Sep; 129(9):1127-30. PubMed ID: 21911661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation.
    Gragoudas ES; Li W; Lane AM; Munzenrider J; Egan KM
    Ophthalmology; 1999 Aug; 106(8):1571-7; discussion 1577-8. PubMed ID: 10442906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.